A Glance at the Use of Glucocorticoids in Rare Inflammatory and Autoimmune Diseases: Still an Indispensable Pharmacological Tool?
Since their discovery, glucocorticoids (GCs) have been used to treat almost all autoimmune and chronic inflammatory diseases, as well as allergies and some forms of malignancies, because of their immunosuppressive and anti-inflammatory effects. Although GCs provide only symptomatic relief and do not...
Main Authors: | Simona Ronchetti, Emira Ayroldi, Erika Ricci, Marco Gentili, Graziella Migliorati, Carlo Riccardi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.613435/full |
Similar Items
-
Implicating the Role of GILZ in Glucocorticoid Modulation of T-Cell Activation
by: Lorenza Cannarile, et al.
Published: (2019-08-01) -
Glucocorticoid-Induced Leucine Zipper (GILZ) in Cardiovascular Health and Disease
by: Donato Cappetta, et al.
Published: (2021-08-01) -
Glucocorticoid-Induced Leucine Zipper Inhibits Interferon-Gamma Production in B Cells and Suppresses Colitis in Mice
by: Stefano Bruscoli, et al.
Published: (2018-07-01) -
Non-canonical Glucocorticoid Receptor Transactivation of gilz by Alcohol Suppresses Cell Inflammatory Response
by: Hang Pong Ng, et al.
Published: (2017-06-01) -
Glucocorticoid-Induced Leucine Zipper: A Promising Marker for Monitoring and Treating Sepsis
by: Ya-Jun He, et al.
Published: (2020-12-01)